More Articles
Medtronic has added a new device, the Penditure Left Atrial Appendage (LAA) Exclusion System, to its cardiac surgery portfolio. The device was designed for the exclusion of the LAA in patients undergoing concomitant heart surgeries, a…
Bayer has ended a clinical trial for its new atrial fibrillation (AFib) drug much earlier than planned based on recommendations from the Independent Data Monitoring Committee (IDMC).…
Medtronic has gained European CE mark approval for its PulseSelect Pulsed Field Ablation (PFA) System and the Nitron CryoConsole.
PulseSelect, designed to treat atrial fibrillation (AFib), is a key…
The use of artificial intelligence (AI) to evaluate and treat heart disease has been one of the biggest stories at the…
The International Liaison Committee on Resuscitation (ILCOR), a global group focused on improving patient outcomes after in-hospital cardiac arrest (IHCA), has shared 10 steps hospitals can take to…
Treating paroxysmal atrial fibrillation (AFib) with a next-generation radiofrequency (RF) catheter from Biosense Webster, a Johnson and Johnson MedTech company, is associated with significant improvements in quality of life (QOL),…
Researchers from Google have introduced a new approach for cardiac monitoring that relies on the active noise canceling (ANC) technology found in headphones and earbuds.
The technique,…
Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The…
Transcatheter aortic valve replacement (TAVR) has been one of the hottest topics in…
Medtronic has gained U.S. Food and Drug Administration (FDA) approval for a new first-of-its-kind extravascular implantable cardioverter-defibrillator (ICD) and defibrillation lead that allows…
Advanced artificial intelligence (AI) models can be trained to identify abnormal…
Augmented reality is becoming more common in healthcare settings, with St. Louis-based developer …
Specialists at Cleveland Clinic have treated a hypertrophic cardiomyopathy (HCM) patient with a new gene therapy designed to reverse disease progression.
…
Nearly one-fifth of patients die within two years of undergoing transcatheter aortic valve replacement (TAVR), according to a new analysis…
Cardiologists are often not too concerned when atrial arrhythmias occur during the 90-day “blanking period” after catheter ablation. According to a new analysis published in JACC: Clinical Electrophysiology, however, such…
Cardiologists can safely perform routine electrophysiology (EP) studies during…
Attune Medical, the Chicago-based healthcare technology company, has received a De Novo…
Non-vitamin K oral anticoagulants (NOACs) are associated with fewer major bleeding events and deaths than vitamin K antagonists (VKAs) when treating patients who develop new-onset atrial fibrillation (AFib) after…